XML 46 R36.htm IDEA: XBRL DOCUMENT
v3.23.3

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Disaggregation of Revenue [Abstract] |
Disaggregation of Revenue [Table Text Block] | The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.
| Three Months Ended September 30, |  |
| 2023 |  | 2022 |  |  |  |
Businesses | U.S. |  | Int'l |  | Total |  | U.S. |  | Int'l |  | Total |  |  |  |  |  |  |  |
Endoscopy | $ | 382 |  |  | $ | 247 |  |  | $ | 629 |  |  | $ | 342 |  |  | $ | 217 |  |  | $ | 559 |  |  |  |  |  |  |  |  |
Urology | 341 |  |  | 142 |  |  | 483 |  |  | 315 |  |  | 118 |  |  | 433 |  |  |  |  |  |  |  |  |
Neuromodulation | 175 |  |  | 55 |  |  | 229 |  |  | 173 |  |  | 48 |  |  | 221 |  |  |  |  |  |  |  |  |
MedSurg | 898 |  |  | 443 |  |  | 1,341 |  |  | 830 |  |  | 383 |  |  | 1,213 |  |  |  |  |  |  |  |  |
Interventional Cardiology Therapies | 182 |  |  | 401 |  |  | 583 |  |  | 190 |  |  | 359 |  |  | 549 |  |  |  |  |  |  |  |  |
Watchman | 291 |  |  | 31 |  |  | 323 |  |  | 234 |  |  | 28 |  |  | 262 |  |  |  |  |  |  |  |  |
Cardiac Rhythm Management | 355 |  |  | 197 |  |  | 552 |  |  | 338 |  |  | 181 |  |  | 519 |  |  |  |  |  |  |  |  |
Electrophysiology | 89 |  |  | 101 |  |  | 190 |  |  | 73 |  |  | 75 |  |  | 148 |  |  |  |  |  |  |  |  |
Cardiology | 918 |  |  | 730 |  |  | 1,647 |  |  | 836 |  |  | 643 |  |  | 1,479 |  |  |  |  |  |  |  |  |
Peripheral Interventions | 283 |  |  | 255 |  |  | 538 |  |  | 269 |  |  | 210 |  |  | 479 |  |  |  |  |  |  |  |  |
Cardiovascular | 1,201 |  |  | 984 |  |  | 2,185 |  |  | 1,104 |  |  | 853 |  |  | 1,958 |  |  |  |  |  |  |  |  |
Total Net Sales | $ | 2,099 |  |  | $ | 1,427 |  |  | $ | 3,527 |  |  | $ | 1,934 |  |  | $ | 1,236 |  |  | $ | 3,170 |  |  |  |  |  |  |  |  |
| Nine Months Ended September 30,
| 2023 |  | 2022
Businesses | U.S. |  | Int'l |  | Total |  | U.S. |  | Int'l |  | Total
Endoscopy | $ | 1,118 |  |  | $ | 719 |  |  | $ | 1,836 |  |  | $ | 992 |  |  | $ | 657 |  |  | $ | 1,649 |
Urology | 1,007 |  |  | 430 |  |  | 1,437 |  |  | 921 |  |  | 375 |  |  | 1,296 |
Neuromodulation | 530 |  |  | 177 |  |  | 708 |  |  | 519 |  |  | 150 |  |  | 669 |
MedSurg | 2,655 |  |  | 1,326 |  |  | 3,981 |  |  | 2,432 |  |  | 1,182 |  |  | 3,614 |
Interventional Cardiology Therapies | 554 |  |  | 1,248 |  |  | 1,803 |  |  | 568 |  |  | 1,099 |  |  | 1,667 |
Watchman | 843 |  |  | 87 |  |  | 930 |  |  | 662 |  |  | 76 |  |  | 738 |
Cardiac Rhythm Management | 1,057 |  |  | 609 |  |  | 1,665 |  |  | 1,005 |  |  | 575 |  |  | 1,580 |
Electrophysiology | 259 |  |  | 300 |  |  | 560 |  |  | 196 |  |  | 222 |  |  | 418 |
Cardiology | 2,714 |  |  | 2,244 |  |  | 4,958 |  |  | 2,431 |  |  | 1,972 |  |  | 4,403 |
Peripheral Interventions | 844 |  |  | 733 |  |  | 1,577 |  |  | 782 |  |  | 641 |  |  | 1,423 |
Cardiovascular | 3,557 |  |  | 2,977 |  |  | 6,534 |  |  | 3,213 |  |  | 2,613 |  |  | 5,826 |
Total Net Sales | $ | 6,212 |  |  | $ | 4,303 |  |  | $ | 10,515 |  |  | $ | 5,645 |  |  | $ | 3,795 |  |  | $ | 9,440 |
Refer to Note K- Segment Reporting for information on our reportable segments.
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Geographic Regions | 2023 |  | 2022 |  | 2023 |  | 2022
U.S. | $ | 2,099 |  |  | $ | 1,934 |  |  | $ | 6,212 |  |  | $ | 5,645 |
Europe, Middle East and Africa | 671 |  |  | 585 |  |  | 2,107 |  |  | 1,869 |
Asia-Pacific | 611 |  |  | 532 |  |  | 1,784 |  |  | 1,579 |
Latin America and Canada | 146 |  |  | 119 |  |  | 412 |  |  | 347 |
Total Net Sales | $ | 3,527 |  |  | $ | 3,170 |  |  | $ | 10,515 |  |  | $ | 9,440 |
Emerging Markets(1) | $ | 594 |  |  | $ | 519 |  |  | $ | 1,715 |  |  | $ | 1,457 |
(1)Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation.

X
- References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration